0001209191-19-043260.txt : 20190725 0001209191-19-043260.hdr.sgml : 20190725 20190725185030 ACCESSION NUMBER: 0001209191-19-043260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190723 FILED AS OF DATE: 20190725 DATE AS OF CHANGE: 20190725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUNST ROBERT A CENTRAL INDEX KEY: 0001247930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 19975608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-23 0 0001006045 IRIDEX CORP IRIX 0001247930 GUNST ROBERT A 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2019-07-23 4 A 0 11204 0.00 A 23304 D Stock Option (right to buy) 3.57 2019-07-23 4 A 0 15000 0.00 A 2026-07-23 Common Stock 15000 15000 D Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule16b-3. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on August 23, 2019 and each month thereafter. /s/ Nilo De Castro, Attorney-in-Fact for Robert A. Gunst 2019-07-25